These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 3566189)

  • 1. Melphalan-induced DNA cross-linking in human melanoma cells and phytohaemagglutinin-stimulated lymphocytes in relation to intracellular drug content and cellular levels of glutathione.
    Hansson J; Edgren M; Ehrsson H; Lewensohn R; Ringborg U
    Anticancer Res; 1987; 7(1):97-104. PubMed ID: 3566189
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Different melphalan toxicity and DNA cross-linking in human melanoma cells as compared to phytohaemagglutinin-stimulated lymphocytes.
    Hansson J; Lewensohn R; Ringborg U
    Anticancer Res; 1985; 5(5):471-7. PubMed ID: 4062251
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Melphalan-induced DNA cross-linking and inhibition of DNA and RNA synthesis in human melanoma and lymphoblast cells.
    Ringborg U; Hansson J; Jungnelius U; Lewensohn R; Skog S
    Anticancer Res; 1990; 10(2A):297-301. PubMed ID: 2346304
    [TBL] [Abstract][Full Text] [Related]  

  • 4. L-phenylalanine mustard (melphalan) uptake and cross-linking in the RPMI 6410 human lymphoblastoid cell line.
    Brox LW; Gowans B; Belch A
    Cancer Res; 1980 Apr; 40(4):1169-72. PubMed ID: 7357546
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of D,L-buthionine-S,R-sulfoximine on cytotoxicity and DNA cross-linking induced by bifunctional DNA-reactive cytostatic drugs in human melanoma cells.
    Hansson J; Edgren M; Ehrsson H; Ringborg U; Nilsson B
    Cancer Res; 1988 Jan; 48(1):19-26. PubMed ID: 3334994
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytotoxicity and DNA cross-linking induced by peptide conjugated m-L-sarcolysin in human melanoma cells.
    Hansson J; Lewensohn R; Ringborg U
    Anticancer Res; 1991; 11(5):1725-30. PubMed ID: 1768043
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanism of melphalan resistance developed in vitro in human melanoma cells.
    Parsons PG; Carter FB; Morrison L; Regius Mary Sister
    Cancer Res; 1981 Apr; 41(4):1525-34. PubMed ID: 6163526
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Formation and removal of DNA cross-links induced by melphalan and nitrogen mustard in relation to drug-induced cytotoxicity in human melanoma cells.
    Hansson J; Lewensohn R; Ringborg U; Nilsson B
    Cancer Res; 1987 May; 47(10):2631-7. PubMed ID: 3567896
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alkylator resistance in human B lymphoid cell lines: (1). Melphalan accumulation, cytotoxicity, interstrand-DNA-crosslinks, cell cycle analysis, and glutathione content in the melphalan-sensitive B-lymphocytic cell line (WIL2) and in the melphalan-resistant B-CLL cell line (WSU-CLL).
    Pu Q; Bianchi P; Bezwoda WR
    Anticancer Res; 2000; 20(4):2561-8. PubMed ID: 10953327
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sensitization of human melanoma cells to the cytotoxic effect of melphalan by the glutathione transferase inhibitor ethacrynic acid.
    Hansson J; Berhane K; Castro VM; Jungnelius U; Mannervik B; Ringborg U
    Cancer Res; 1991 Jan; 51(1):94-8. PubMed ID: 1988111
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential DNA cross-linking and cytotoxicity in PHA-stimulated human lymphocytes exposed to melphalan, m-L-sarcolysin and peptichemio.
    Lewensohn R; Hansson J; Ringborg U; Ehrsson H
    Eur J Cancer Clin Oncol; 1987 Jun; 23(6):783-8. PubMed ID: 3653195
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transport, metabolism, and DNA interaction of melphalan in lymphocytes from patients with chronic lymphocytic leukemia.
    Panasci L; Henderson D; Torres-Garcia SJ; Skalski V; Caplan S; Hutchinson M
    Cancer Res; 1988 Apr; 48(7):1972-6. PubMed ID: 3349471
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dependence on treatment time of melphalan resistance and DNA cross-linking in human melanoma cell lines.
    Parsons PG
    Cancer Res; 1984 Jul; 44(7):2773-8. PubMed ID: 6722805
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DNA damage in cyclophosphamide-resistant tumor cells: the role of glutathione.
    Richardson ME; Siemann DW
    Cancer Res; 1995 Apr; 55(8):1691-5. PubMed ID: 7712476
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased toxicity and DNA cross-linking by peptide bound m-L-sarcolysin (Peptichemio) as compared to melphalan and m-L-sarcolysin in human melanoma cell lines.
    Lewensohn R; Ehrsson H; Hansson J; Ringborg U
    Anticancer Res; 1991; 11(1):321-4. PubMed ID: 2018366
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of alpha-difluoromethylornithine on L-phenylalanine mustard-induced cytotoxicity and DNA interstrand cross-linking in a human cell line in vitro.
    Ducore JM; McNamara L
    Cancer Res; 1986 Mar; 46(3):1068-72. PubMed ID: 3080230
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gene-specific formation and repair of DNA monoadducts and interstrand cross-links after therapeutic exposure to nitrogen mustards.
    Souliotis VL; Dimopoulos MA; Sfikakis PP
    Clin Cancer Res; 2003 Oct; 9(12):4465-74. PubMed ID: 14555520
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhanced DNA cross-link removal: the apparent mechanism of resistance in a clinically relevant melphalan-resistant human breast cancer cell line.
    Batist G; Torres-Garcia S; Demuys JM; Greene D; Lehnert S; Rochon M; Panasci L
    Mol Pharmacol; 1989 Aug; 36(2):224-30. PubMed ID: 2770701
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development and characterization of a melphalan-resistant human multiple myeloma cell line.
    Bellamy WT; Dalton WS; Gleason MC; Grogan TM; Trent JM
    Cancer Res; 1991 Feb; 51(3):995-1002. PubMed ID: 1988143
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Depletion of cellular glutathione by N,N'-bis(trans-4-hydroxycyclohexyl)-N'-nitrosourea as a determinant of sensitivity of K562 human leukemia cells to 4-hydroperoxycyclophosphamide.
    Chresta CM; Crook TR; Souhami RL
    Cancer Res; 1990 Jul; 50(13):4067-71. PubMed ID: 2354456
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.